Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...
The first under-the-skin, long-acting risperidone injection offers a new maintenance option for adults with bipolar 1 disorder. For anyone managing bipolar 1 disorder, staying consistent with daily ...
Researchers conducted a case series study of 15 pregnant and postpartum patients with OUD treated with extended-release buprenorphine between January 1, 2023, and May 1, 2025, in an urban academic ...
BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of ...
In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results